ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

Two Workshops To Look For New Research Areas

October 29, 1976

Reponses To Ford’s Request For Scientific Rational Of Cigarette Regulation Based On Epidemiologic Studies

November 8, 1974

Funding Opporunities: Program Announcments

January 15, 1999

Social Networks Influence Decision To Quit Smoking

May 30, 2008